MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural ...

Three abstracts accepted for presentation, including one rapid oral abstract sessionPresentations to highlight ongoing clinical and translational research across PDS Biotechnology’s immunotherapy ...

Three abstracts accepted for presentation, including one rapid oral abstract sessionPresentations to highlight ongoing clinical and translational ...

An announcement from CERo Therapeutics Holdings ( ($CERO) ) is now available. On October 29, 2025, CERo Therapeutics Holdings announced that its ...

CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they ...

Trading of the Company’s shares of common stock on Nasdaq will be suspended at the open of trading on October 31 . CERo plans to appeal the Panel determination, seek trading of ...

Abstract: The Age of Information (AoI) is a key metric in monitoring and control applications of Internet of Things (IoT) networks, where real-time decision-making relies on the freshness of the ...

Lifelong viral infections can quietly alter the immune system, with effects that persist over the time. Viruses such as the ...

The field of bacteriophage research is rapidly evolving, offering new perspectives on the complex interplay between phages, bacteria, and host immune ...

Researchers uncover that ALV-J boosts miR-155 to suppress TRAF3 and STAT1, weakening immune responses and promoting viral ...

Two therapies can be better than one for treating some cancers, concludes a Yale study published Oct. 22 in JCI Insight that ...